Shanghai Henlius Biotech Inc

Common Name
Shanghai Henlius Biotech
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
3,515
Ticker
2696
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Shanghai Henlius Biotech Inc. is a leading biopharmaceutical company specializing in the development of innovative monoclonal antibody (mAb) drugs. As a pivotal player in the biotechnology industry, H...

Shanghai Henlius Biotech Waste Data Preview

In 2023, Shanghai Henlius Biotech conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Shanghai Henlius Biotech’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Shanghai Henlius Biotech generated a total of 643 metric tonnes of waste.

Of this amount, 35.32% of Shanghai Henlius Biotech's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 64.68% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Shanghai Henlius Biotech’s Hazardous vs Non-Hazardous Waste Over Time

20212022202302505007501 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Shanghai Henlius Biotech reduced the environmental impact of its waste?

Since 2021, Shanghai Henlius Biotech's total waste generation decreased by 16.36%, with an additional 24.86% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.

Over the same period, the share of hazardous waste in Shanghai Henlius Biotech's total output increased by 53.13%, including a further 36.21% rise in 2023, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.

Overall, Shanghai Henlius Biotech's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.

Want Full Access to Shanghai Henlius Biotech's Waste Management Dataset?
Sign Up